Page 4 - R Pac Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJack perkinsMichaelj pishvaianShripal gandhiShaun bagaiVascular instituteCompany nasdaqMiami cancer instituteExchange commissionImugene ltdNasdaq stock marketSchool of medicineStrategic communicationsData monitoring committeeRenovorx incSecurities exchange

RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights

Presented positive Phase III TIGeR-PaC interim study results observing 8-month delay in cancer progression, concordant with 6-month overall survival benefit and 65% reduction in adverse effects over.

United statesRobertj spiegelShaun bagaiMargareta temperoUniversity of texas southwestern medical centerPancreas cancer programExchange commissionCompany board of directorsRenovorx incWorld congressSecurities exchangeCompany nasdaqAmerican association for cancer research annual meetingCompany scientific advisory boardPancreas centerImugene ltd

RenovoRx, Inc Stock Surges After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)

RenovoRx, Inc. shares surged by 37% on massive volume after the company provided a positive update from its TIGeR-PaC trial. While profit-taking took the momentum from the rally, RNXT shares are.

Columbia universityNew yorkUnited statesShaun bagaiMichaelj pishvaianMichael thomasTiger pac data monitoring committeeUt southwestern medical centerStm llcRenovorx incWorld congress on gastrointestinal cancerPresbyterian hospital irving medical centerShore thing mediaUniversity of texas ut southwestern medical centerGastrointestinal cancerHopkins medicine

RenovoRx (RNXT) Announces New Positive Interim Phase III Data Demonstrating RenovoGem Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer

RenovoRx (RNXT) Announces New Positive Interim Phase III Data Demonstrating RenovoGem Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj pishvaianShaun bagaiJack perkinsStrategic communicationsRenovorx incExchange commissionWorld congress on gastrointestinal cancerTiger pac data monitoring committeeSecurities exchangeAmerican cancer society facts figuresGastrointestinal cancerJohns hopkins medicinePrincipal investigatorR pac data monitoring committeeTrans arterial micro perfusion

RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer

RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShaun bagaiMichaelj pishvaianJack perkinsRenovorx incSecurities exchangeTiger pac data monitoring committeeStrategic communicationsAmerican cancer society facts figuresExchange commissionCompany nasdaqWorld congress on gastrointestinal cancerSix month overall survival benefitLocally advanced pancreaticGastrointestinal cancerJohns hopkins medicine